Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merging thoughts

This article was originally published in The Tan Sheet

Executive Summary

Warner-Lambert announces Jan. 13 it is "exploring strategic alternatives" to American Home Products' merger offer, "including meeting with Pfizer." The announcement, which makes an AmericanWarner merger appear unlikely, might have been spurred by shareholder pressure; W-L acknowledges Pfizer's bid "is better financially" than the proposed deal with AHP. Negotiations could focus on the size of Pfizer's bid. The company originally offered 2.5 shares per W-L share, however, since Pfizer's stock price slipped, the value of such a deal has changed. By market close Jan. 14, 2.5 Pfizer shares were worth 92-1/2, compared to 93-11/16 for a W-L share. In any case, the companies will have until Feb. 14 to talk, which is when a Delaware chancery court is scheduled to hear W-L's complaint seeking to end the Lipitor marketing agreement it has with Pfizer
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel